Skip to main content
Premium Trial:

Request an Annual Quote

Keygene's Deployment of Illumina and 454 Sequencers Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, April 20.
1. Keygene Buys Illumina Analyzer and Upgrades its 454 Sequencer (from April 16)
2. Affymetrix, NuGen to Co-Market FFPE Sampling and GeneChip Combo (from April 17)
3. FDA Clears Cepheid's PCR-based Drug-Resistant S. aureus Test (from April 18)
4. VC Spending on -omics Shops Slides 25 Percent in Q1, But Proteomics, Genomics Grows (from April 18)
5. Affymetrix to Fund European Cancer Studies Using Microarrays (from April 17)
The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.